These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 6256437)

  • 1. Regulation of human polymorphonuclear leukocyte superoxide release by cellular responses to chemotactic peptides.
    English D; Roloff JS; Lukens JN
    J Immunol; 1981 Jan; 126(1):165-71. PubMed ID: 6256437
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased expression of C3b receptors on polymorphonuclear leukocytes induced by chemotactic factors and by purification procedures.
    Fearon DT; Collins LA
    J Immunol; 1983 Jan; 130(1):370-5. PubMed ID: 6847888
    [No Abstract]   [Full Text] [Related]  

  • 3. Stimulus-specific deactivation of chemotactic factor-induced cyclic AMP response and superoxide generation by human neutrophils.
    Simchowitz L; Atkinson JP; Spilberg I
    J Clin Invest; 1980 Oct; 66(4):736-47. PubMed ID: 6252250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotactic deactivation of human neutrophils: relationship to loss of cytotaxin receptor function and temporal nature of the phenomenon.
    Nelson RD; Fiegel VD; Herron MJ; Simmons RL
    J Reticuloendothel Soc; 1980 Sep; 28(3):285-94. PubMed ID: 7411541
    [No Abstract]   [Full Text] [Related]  

  • 5. The effects of an ECF-A and formyl methionyl chemotactic peptides on oxidative metabolism of human eosinophils and neutrophils.
    Beswick PH; Kay AB
    Clin Exp Immunol; 1981 Feb; 43(2):399-407. PubMed ID: 6268337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of cytochalasin A on polymorphonuclear leukocytes activated by chemotactic peptide.
    Elferink JG; Riemersma JC
    J Reticuloendothel Soc; 1981 Feb; 29(2):163-71. PubMed ID: 6260942
    [No Abstract]   [Full Text] [Related]  

  • 7. Production of superoxide by neutrophils.
    West MY; Sinclair DS; Southwell-Keely PT
    Experientia; 1983 Jan; 39(1):61-2. PubMed ID: 6297957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diverging effects of chemotactic serum peptides and synthetic f-Met-Leu-Phe on neutrophil locomotion and adhesion.
    Keller HU; Wissler JH; Damerau B
    Immunology; 1981 Mar; 42(3):379-83. PubMed ID: 7203527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotaxis, spreanding nd oxidative metabolism of neutrophils: influence of albumin in vitro.
    Valerius NH
    Acta Pathol Microbiol Immunol Scand C; 1983 Feb; 91(1):43-9. PubMed ID: 6306991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional changes of neutrophil responses in relapsing acne fulminans.
    Christophers E; Schröder JM
    Acta Derm Venereol Suppl (Stockh); 1985; 120():30-3. PubMed ID: 3010614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotactic factor-induced superoxide radical generation by human neutrophils: requirement for proteinase (esterase) activity.
    Simchowitz L; Mehta J; Spilberg I
    J Lab Clin Med; 1979 Sep; 94(3):403-13. PubMed ID: 224122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of filter-bound IgA in inhibiting polymorphonuclear leukocyte chemotaxis.
    Schröder JM; Christophers E
    Immunobiology; 1983 Mar; 164(2):127-35. PubMed ID: 6852861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A monoclonal antibody-inhibiting FMLP-induced chemotaxis of human neutrophils.
    Cotter TG; Keeling PJ; Henson PM
    J Immunol; 1981 Dec; 127(6):2241-5. PubMed ID: 7053244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective defect in human neutrophil superoxide anion generation elicited by the chemoattractant N-formylmethionylleucylphenylalanine in pregnancy.
    Cotton DJ; Seligmann B; O'Brien WF; Gallin JI
    J Infect Dis; 1983 Aug; 148(2):194-9. PubMed ID: 6310000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular control of human neutrophil secretion. II. Stimulus specificity of desensitization induced by six different soluble and particulate stimuli.
    Henson PM; Schwartzman NA; Zanolari B
    J Immunol; 1981 Aug; 127(2):754-9. PubMed ID: 7019331
    [No Abstract]   [Full Text] [Related]  

  • 16. Neutrophil dysfunction in sepsis. II. Evidence for the role of complement activation products in cellular deactivation.
    Solomkin JS; Jenkins MK; Nelson RD; Chenoweth D; Simmons RL
    Surgery; 1981 Aug; 90(2):319-27. PubMed ID: 7256544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil aggregation: effect of the time and sequence of addition of calcium, magnesium and chemotactic factor.
    O'Flaherty JT; Showell HS; Becker EL; Ward PA
    J Reticuloendothel Soc; 1979 Jan; 25(1):29-38. PubMed ID: 430469
    [No Abstract]   [Full Text] [Related]  

  • 18. Regulation of neutrophil inflammatory mediator release: chemotactic peptide activation of stimulus-dependent cytotoxicity.
    English D; Lukens JN
    J Immunol; 1983 Feb; 130(2):850-6. PubMed ID: 6294178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of vitamin K on human neutrophil function.
    Gallin JI; Seligmann BE; Cramer EB; Schiffmann E; Fletcher MP
    J Immunol; 1982 Mar; 128(3):1399-408. PubMed ID: 6276468
    [No Abstract]   [Full Text] [Related]  

  • 20. Transmembrane potential changes associated with superoxide release from human granulocytes.
    Jones GS; VanDyke K; Castranova V
    J Cell Physiol; 1981 Jan; 106(1):75-83. PubMed ID: 6259186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.